clinion

On this Page

  • What is a Double-Blind Study in clinical trials?
  • Where is it used in clinical trials?
  • How does Clinion implement it?
  • What does it look like in practice?
  • Related Terms
  • Related Articles
  • Category

What is a Double-Blind Study in clinical trials?

A double-blind study is a clinical trial design in which neither participants nor investigators know the treatment assigned to each participant. By preventing knowledge of allocation, this design reduces bias during clinical evaluation and outcome analysis, supporting objective and scientifically reliable results.

Where is it used in clinical trials?

Double-blind studies are applied in interventional trials where awareness of treatment could influence participant behavior or investigator assessments. They are common in mid- to late-phase trials evaluating investigational drugs or biologics, particularly when comparing outcomes against a placebo or standard treatment. This design helps maintain consistency in assessments, minimizes subjective influence, and is often expected by regulators for studies with comparative efficacy endpoints.

How does Clinion implement it?

Clinion implements double-blind studies using its integrated RTSM framework, which handles randomization, treatment assignment, and controlled access to allocation information. User roles are configured to enforce blinding rules, and emergency unblinding is managed through predefined system procedures. The platform automatically captures all allocation-related activities, ensuring traceability, protocol compliance, and alignment with regulatory requirements.

What does it look like in practice?

In a Clinion-managed double-blind study, the site team enrolls participants and enters baseline information into the eCRF. Participants are randomized via Clinion’s RTSM module, with treatment assignments concealed from blinded users. Investigators review visit data, record clinical assessments, and monitor adverse events without access to allocation details. If emergency unblinding is needed, authorized personnel follow a system-guided process, which is automatically logged. Verified data then progresses to the next stage for monitoring and sponsor review, maintaining a clear, traceable workflow.

Category

RTSM